Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence
NCT ID: NCT01397266
Last Updated: 2011-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
20 participants
INTERVENTIONAL
2010-03-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients
NCT01259362
Repetitive Transcranial Magnetic Stimulation in Symptoms of Attention Deficit Hyperactivity Disorder and Cognitive Function In Cocaine Addicts
NCT01593982
Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity.
NCT02986438
Effect of rTMS on Neurotrophines Levels in CUD
NCT05824221
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
NCT05974202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active TMS
active rTMS delivered to the left dorsolateral prefrontal cortex
Transcranial Magnetic Stimulation
ACTIVE rTMS delivered to the left dorsolateral prefrontal cortex
Placebo TMS
PLACEBO rTMS delivered to the left dorsolateral prefrontal cortex
Placebo TMS
PLACEBO rTMS delivered to the left dorsolateral prefrontal cortex
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Magnetic Stimulation
ACTIVE rTMS delivered to the left dorsolateral prefrontal cortex
Placebo TMS
PLACEBO rTMS delivered to the left dorsolateral prefrontal cortex
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 20 days or less withdrawal
3. 18-35 years old.
4. If female, to be using contraception (barrier, oral contraceptive, IUD, surgical sterilization).
5. Fixed residential address in Sao Paulo
Exclusion Criteria
2. organic brain disease, neurosurgery to implant metal clip or epilepsy.
3. severe uncontrolled clinical comorbidity.
4. use current or within last six months of psychotropic drugs in general, except for Clonazepam dose of up to four mg / day.
5. Changes clinically significant laboratory findings. 13
6. Condition or situation to which in the opinion of the investigator put the patient at risk significant, which may confound the results, or interfere substantially in individual's participation in the study.
7. Mandate that mandating the judicial treatment for cocaine dependence
18 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
USaoPauloGH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adan Jardim
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department and Institute of Psychiatry, General Hospital, University of São Paulo Medical School
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ádan Jardim
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ádan P JArdim
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1339/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.